BioClinica, a global provider of clinical trial management solutions, has announced that Europe was the fastest growing geographic region in 2013 for its eClinical technology products. The company plans continued investments in its European workforce in of operations and sales, potentially doubling its European eClinical presence in 2014.

The growing team supports BioClinica's suite of eClinical offerings, including CTMS, EDC, IRT and clinical supplies planning. Currently, the company has employees in corporate offices in France, the Netherlands and Germany, with additional personnel in Switzerland, Belgium and the U.K.

Martijn Princen, BioClinica's head of European eClinical sales, said, "One of the pillars for success in this or any geographic market essentially is the eClinical technology itself. With a web-based, easy-to-use platform, supported by experienced people on the ground here in Europe, more and more companies are selecting BioClinica for both European and global studies."

BioClinica's European customer base includes pharmaceutical, biotechnology and medical device companies, with CROs and mid-market organizations comprising the largest new market share.

"In terms of innovation, OnPoint CTMS and Trident IRT have been the big attention-getters, driven by the need for better speed and flexibility that is central to clinical research. For example, a CTMS needs to grow with an organization and have capacity to manage complex clinical trials long-term," said Princen. "Now the trend is for large and mid-size sponsors and CROs to replace their existing CTMS with a more sophisticated end-to-end clinical trial management solution."

BioClinica is experiencing increased demand for IRT and EDC solutions, particularly by CROs. This comes on the heels of several major IRT and EDC implementations, including one study with 17,000 subjects and 442 sites in 17 countries.